Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA for symptomatic polycystic liver disease
NL-OMON38971Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ursodeoxycholic acid in Polycystic liver disease (PLD), sponsored by Radboud University Medical Center. Started May 2014; status: active, not recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on NL-OMON38971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38971.